Trial Profile
The Effect of "Funny" Channel Blocker Ivabradine on Patients With Postural Tachycardia Syndrome.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Jan 2013
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Postural orthostatic tachycardia syndrome
- Focus Therapeutic Use
- 24 Jan 2013 New trial record